Replies to post #234458 on Biotech Values

[DewDiligence]

AZN—(-6%/AH)—discloses SAE for one patient in COVID-19–vaccine phase-3 trial—temporary halt in vaccinations:

https://www.express.co.uk/news/uk/1333098/Coronavirus-vaccine-news-study-latest-on-hold-AstraZeneca-university-of-oxford